Literature DB >> 9288152

An ETa/ETb endothelin antagonist ameliorates systemic inflammation in a murine model of acute hemorrhagic pancreatitis.

K E Todd1, M P Lewis, B Gloor, J S Lane, S W Ashley, H A Reber.   

Abstract

BACKGROUND: Endothelin peptides are polykines with strong vasoconstrictor properties. We have previously shown that endothelin antagonism (PD145065) reduces the local severity of acute pancreatitis. We now investigated the effect of endothelin antagonism on systemic inflammation in a model of acute hemorrhagic pancreatitis.
METHODS: Forty-two mice were divided into four groups. Group 1 was fed standard food plus PD145065 every 8 hours. Group 2 was fed a choline-deficient ethionine (CDE) supplemented diet and given saline every 8 hours. Group 3 was fed a CDE diet and treated with PD145065 every 8 hours from initiation of diet. Group 4 was fed a CDE diet and given PD145065 from 48 hours after initiation of diet. Animals were killed at 70 hours. Serum was collected. Pancreata and lung tissue were harvested.
RESULTS: Histology score, serum amylase level, lung myeloperoxidase, and interleukin (IL)-10 were all significantly reduced in both treatment groups (groups 3 and 4) (p < 0.05). IL-6 levels were reduced in group 3 only (p < 0.05). The mortality rate did not differ among any of the groups.
CONCLUSIONS: Endothelin antagonism decreased the severity of acute pancreatitis and reduced markers of systemic inflammation. Late treatment at 48 hours failed to prevent the rise in IL-6. Mortality rates were unaffected by treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288152     DOI: 10.1016/s0039-6060(97)90038-6

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

Review 1.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

2.  The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats.

Authors:  F Fiedler; D Ayasse; P Rohmeiss; N Gretz; C Rehbein; V Keim
Journal:  Int J Pancreatol       Date:  1999-12

3.  Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade.

Authors:  T Foitzik; H G Hotz; G Eibl; B Hotz; M Kirchengast; H J Buhr
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

4.  Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis.

Authors:  A H Lundberg; K Fukatsu; L Gaber; S Callicutt; M Kotb; H Wilcox; K Kudsk; A O Gaber
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

5.  Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist.

Authors:  T Foitzik; G Eibl; H J Buhr
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

6.  Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats.

Authors:  Anna Andrzejewska; Jan-W Dlugosz; Albert Augustynowicz
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Beneficial effect of octreotide treatment in acute pancreatitis in rats.

Authors:  J Marton; Z Szasz; Z Nagy; K Jarmay; T Takacs; J Lonovics; A Balogh; G Farkas
Journal:  Int J Pancreatol       Date:  1998-12

8.  Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis.

Authors:  M E Martignoni; G O Ceyhan; E Ayuni; Y Kondo; A Zimmermann; M W Büchler; H Friess
Journal:  Langenbecks Arch Surg       Date:  2004-05-04       Impact factor: 3.445

9.  The endothelin-1 receptor antagonists ameliorate histology and ultrastructural alterations in the pancreas and decrease trypsinogen activation in severe taurocholate pancreatitis in rats.

Authors:  Anna Andrzejewska; Jan W Dlugosz
Journal:  Int J Exp Pathol       Date:  2003-10       Impact factor: 1.925

10.  Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.

Authors:  Fernanda R C Giachini; Saiprasad M Zemse; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Glaucia E Callera; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.